Spero Therapeutics, Inc. (SPRO) Social Stream
SPERO THERAPEUTICS INC (SPRO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SPERO THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 5 | $40 | $25 | $30.666 | $1.43 | 2044.48% |
| 2022-02-28 | 3 | $40 | $25 | $30.666 | $1.43 | 2044.48% |
| 2022-03-21 | 3 | $43 | $25 | $31.666 | $1.43 | 2114.41% |
| 2022-04-04 | 4 | $43 | $25 | $31.666 | $1.43 | 2114.41% |
| 2022-04-18 | 4 | $37 | $25 | $29.666 | $1.43 | 1974.55% |
| 2022-05-03 | 5 | $37 | $2 | $22 | $1.43 | 1438.46% |
| 2022-05-17 | 5 | $37 | $2 | $14.666 | $1.43 | 925.59% |
| 2022-05-23 | 6 | $10 | $2 | $5.666 | $1.43 | 296.22% |
| 2022-08-11 | 5 | $10 | $2 | $5.666 | $1.43 | 296.22% |
| 2022-09-07 | 5 | $7 | $2 | $4.666 | $1.43 | 226.29% |
| 2022-09-23 | 5 | $8 | $5 | $6.666 | $1.43 | 366.15% |
| 2023-01-26 | 4 | $8 | $5 | $6.333 | $1.43 | 342.87% |
| 2023-04-10 | 5 | $8 | $5 | $6.333 | $1.43 | 342.87% |
| 2023-08-11 | 4 | $8 | $5 | $6.333 | $1.43 | 342.87% |
| 2023-08-14 | 4 | $8 | $5 | $6.666 | $1.43 | 366.15% |
| 2023-11-02 | 3 | $7 | $5 | $6 | $1.43 | 319.58% |
| 2023-11-14 | 3 | $7 | $7 | $7 | $1.43 | 389.51% |
The Trend in the Analyst Price Target
Over the past 42 months, SPRO's average price target has gone down $13.6.
SPRO reports an average of 365.79% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 4 | 8 | 5 | 6.333 | 1.85 | 242.32% |
| 2023-03-31 | 5 | 8 | 5 | 6.333 | 1.45 | 336.76% |
| 2023-08-01 | 4 | 8 | 5 | 6.333 | 1.52 | 316.64% |
| 2023-08-14 | 3 | 7 | 5 | 6.000 | 1.37 | 337.96% |
| 2023-11-14 | 3 | 7 | 7 | 7.000 | 1.09 | 542.2% |
SPRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 39 months, SPRO's average broker recommendation rating worsened by 0.24.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SPRO as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, SPERO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1995.72% of them.
- In terms of how SPERO THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 337.11% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, SPERO THERAPEUTICS INC's average analyst price target is greater than 880.99% of them.
- SPRO has a lower variance in analysts' estimates than -843.49% of Pharmaceutical Products stocks.
Stocks similar to SPERO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RYTM, URGN, and GTHX.
View All Top Stocks by Price Target
Is SPRO a Buy, Hold or Sell? See the POWR Ratings now!